EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access

Similar Efficacy Between Atezolizumab Plus Bevacizumab Versus Hepatic Arterial Infusion Chemotherapy For Unresectable Hepatocellular Carcinoma With Portal Vein Tumor Thrombus: A Retrospective Cohort Study

Akifumi Kuwano, Masayoshi Yada, Kosuke Tanaka, Yuta Koga, Shigehiro Nagasawa, Akihide Masumoto, Kenta Motomura

In Vivo · 2024 · 38 (4) · 1854-1858

DOI: 10.21873/invivo.13639 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift In Vivo, online erschienen am 27.06.2024. Verfasst von Akifumi Kuwano und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatology, Aso Iizuka Hospital, Fukuoka, Japan. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Bevacizumab, Antibodies, Monoclonal, Humanized. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsBevacizumabAntibodies, Monoclonal, HumanizedPortal VeinAntineoplastic Combined Chemotherapy ProtocolsInfusions, Intra-ArterialHumansMaleFemaleMiddle AgedRetrospective StudiesAgedTreatment OutcomeHepatic ArteryPrognosisAdult

Stichwörter der Autor:innen

Hepatocellular carcinomaatezolizumab plus bevacizumabhepatic arterial infusion chemotherapyportal vein tumor thrombus

Substanzen

BevacizumabatezolizumabAntibodies, Monoclonal, Humanized

Autor:innen und Institutionen

  • Department of Hepatology, Aso Iizuka Hospital, Fukuoka, Japan.
  • Department of Hepatology, Aso Iizuka Hospital, Fukuoka, Japan myadah1@aih-net.com.

Zitieren

APA

Kuwano, A., Yada, M., Tanaka, K., Koga, Y., Nagasawa, S., Masumoto, A., & Motomura, K. (2024). Similar Efficacy Between Atezolizumab Plus Bevacizumab Versus Hepatic Arterial Infusion Chemotherapy For Unresectable Hepatocellular Carcinoma With Portal Vein Tumor Thrombus: A Retrospective Cohort Study. In Vivo, 38(4), 1854-1858. https://doi.org/10.21873/invivo.13639

Vancouver

Kuwano A, Yada M, Tanaka K, Koga Y, Nagasawa S, Masumoto A, et al. Similar Efficacy Between Atezolizumab Plus Bevacizumab Versus Hepatic Arterial Infusion Chemotherapy For Unresectable Hepatocellular Carcinoma With Portal Vein Tumor Thrombus: A Retrospective Cohort Study. In Vivo. 2024;38(4):1854-1858. doi:10.21873/invivo.13639

BibTeX
@article{Kuwano2024,
  author = {Kuwano, Akifumi and Yada, Masayoshi and Tanaka, Kosuke and Koga, Yuta and Nagasawa, Shigehiro and Masumoto, Akihide and Motomura, Kenta},
  title = {Similar Efficacy Between Atezolizumab Plus Bevacizumab Versus Hepatic Arterial Infusion Chemotherapy For Unresectable Hepatocellular Carcinoma With Portal Vein Tumor Thrombus: A Retrospective Cohort Study},
  journal = {In Vivo},
  year = {2024},
  volume = {38},
  number = {4},
  pages = {1854--1858},
  doi = {10.21873/invivo.13639}
}
Kostenlos starten →